SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-027285
Filing Date
2015-05-04
Accepted
2015-05-04 16:17:09
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v407835_10q.htm 10-Q 501713
2 EXHIBIT 31.1 v407835_ex31-1.htm EX-31.1 9385
3 EXHIBIT 31.2 v407835_ex31-2.htm EX-31.2 9052
4 EXHIBIT 32.1 v407835_ex32-1.htm EX-32.1 4856
  Complete submission text file 0001144204-15-027285.txt   6439964

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20150331.xml EX-101.INS 973825
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20150331.xsd EX-101.SCH 59162
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20150331_cal.xml EX-101.CAL 48538
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20150331_def.xml EX-101.DEF 311432
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20150331_lab.xml EX-101.LAB 400898
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20150331_pre.xml EX-101.PRE 361326
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 15828643
SIC: 2834 Pharmaceutical Preparations